(Q34638370)

English

Comparison of the efficacy of fexofenadine 120 and 240 mg/day on chronic idiopathic urticaria and histamine-induced skin responses in Japanese populations

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Comparison of the efficacy of fexofenadine 120 and 240 mg/day on chronic idiopathic urticaria and histamine-induced skin responses in Japanese populations (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

based on heuristic

inferred from title

idiopathic urticaria

1 reference

based on heuristic

inferred from title

author name string

Hideaki Tanizaki

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Kyoko Nakahigashi

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Yoshiki Miyachi

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Kenji Kabashima

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

21 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Journal of Dermatological Treatment

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

477-480

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2013.789472

21 January 2018

Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy.

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2013.789472

21 January 2018

Epidermal chemokines and modulation by antihistamines, antibiotics and antifungals

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2013.789472

21 January 2018

Downmodulatory effects of the antihistaminic drug bepotastine on cytokine/chemokine production and CD54 expression in human keratinocytes

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2013.789472

21 January 2018

Antihistaminic drug olopatadine downmodulates CCL17/TARC production by keratinocytes and Langerhans cells

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2013.789472

21 January 2018

Expression of toll-like receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2013.789472

21 January 2018

The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2013.789472

21 January 2018

A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2013.789472

21 January 2018

Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2013.789472

21 January 2018

Identifiers

10.3109/09546634.2013.789472

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34638370&oldid=1987742550"